HopeStage
Back to all studies
WithdrawnNCT02758067

Comparison of the Effectiveness of Brexpiprazole With That of Risperidone

Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.

Medication studyAges 18–65
The study in practice

Understand this study

What is this study about?

Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJune 2016
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
H. Lundbeck A/S
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
From 18 Years to 65 Years
Official registry ID
NCT02758067
Official title
Show the full official title

Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia

Recruitment & locations

Withdrawn

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing brexpiprazole and risperidone to find out how the approaches affect quality of life in adults with schizophrenia.

Who is behind this study?

The study sponsor is H. Lundbeck A/S.

Does this study involve medication?

Yes. The study involves medication, including brexpiprazole and risperidone.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies